Biden Orders More Research on Long COVID

A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.

Written byChristie Wilcox, PhD
| 2 min read
President Biden meeting with a group of people
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Millions of Americans are experiencing the mysterious post–COVID-19 infection syndrome known as long COVID. President Joe Biden pledged Tuesday (April 5) in a presidential memorandum to increase support for patients, including bolstering insurance coverage and accelerating federal research into the underlying causes in the hopes of providing some relief.

“This is the first effort that truly comports with the needs of people who are suffering,” Diana Berrent, founder of the long COVID support group Survivor Corps, tells the Associated Press.

In the memorandum, Biden called on the Secretary of the Department of Health and Human Services (HHS) to “coordinate a new effort across the federal government to develop and issue the first-ever interagency national research action plan on Long COVID,” according to a White House fact sheet. The plan must include expanding the large NIH study already underway, and “will advance progress in prevention, diagnosis, treatment, and provision of services, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies